Klotho Neurosciences, Inc. (KLTO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 0.41 |
| Open | 0.41 |
| Day High | 0.41 |
| Day Low | 0.37 |
| 52-Week High | 3.91 |
| 52-Week Low | 0.11 |
| Volume | 95,000 |
| Average Volume | 3.23M |
| Market Cap | 20.08M |
| PE | -1.27 |
| EPS | -0.3 |
| Moving Average 50 Days | 0.34 |
| Moving Average 200 Days | 0.63 |
| Change | -0.03 |
Data not available
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco
GlobeNewswire Inc.
Jan 08, 2025 4:00 PM GMT
Company to present at 3:00 p.m. PT on Tuesday, January 14, at the Hilton San Francisco Union SquareNEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell a
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board
GlobeNewswire Inc.
Dec 09, 2024 4:00 PM GMT
Klotho Neurosciences, Inc. continues to strengthen its advisory teams with recent new additions of Neuroscience and Big Pharma leaders to Scientific Advisory Board and Board of DirectorsNEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Klotho Neuroscienc
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
GlobeNewswire Inc.
Dec 03, 2024 4:00 PM GMT
Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board ExpertiseNEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies fo